Skip to main content
. Author manuscript; available in PMC: 2011 Mar 2.
Published in final edited form as: J Urol. 2010 Oct 16;184(6):2313–2319. doi: 10.1016/j.juro.2010.08.012

Table 3.

Incidence of markedly abnormal changes in QTcF from baseline in subjects with QRS 120 msec or less at baseline

Degarelix 240/80 mg Degarelix 240/160 mg Pooled Degarelix Leuprolide 7.5 mg
No. with normal baseline value + post-baseline value recorded 189 184 373 181
No. msec post-baseline QTcF (%):
 450 or Greater 35 (19) 27 (15) 62 (17) 28 (15)
 480 or Greater 4 (2) 3 (2) 7 (2) 4 (2)
 500 or Greater 2 (1) 0 2 (less than 1) 2 (1)

Subjects with QTcF 480 or more and 500 or more msec are included in the total for 450 or more msec.